In what may prove to be a landmark case for victims of mesothelioma, opening statements recently began in New Jersey’s first lawsuit focused on Johnson & Johnson talcum powder products.
About the case
The case is being heard in the Garden State, where the personal hygiene and baby needs products corporation is based. But mesothelioma victims across the country and world are acutely aware of the litigation. The outcome could have a profound and widespread impact on similar cases and future civil lawsuits.
The lawsuit alleges asbestos found in Johnson & Johnson products, such as the company’s Shower to Shower and Baby Powder present a significant cancer-causing danger. Judge Ana Viscomi at the Middlesex County Superior Court is presiding.
Highly anticipated trial
In other litigation, juries have delivered multi-million-dollar awards over products that caused ovarian cancer. However, litigation over mesothelioma and talcum powder has had mixed results so far. The New Jersey suit could take a significant step forward for mesothelioma because it addresses lung cancer connected to inhaling the asbestos particles found in talcum powders. Both mesothelioma and lung cancer are fatal.
The plaintiffs in the New Jersey court battle are asserting that Johnson & Johnson had full knowledge that asbestos was being used in its talc-based products. During the decades-long practice, Johnson & Johnson failed to warn consumers about the danger of inhaling the asbestos when using the product as directed.
The trial has been scheduled to run through February. The case could pave the way for victims of asbestos-related illnesses finally getting their day in court.